×

Dosage forms of bisphosphonates

DC CAFC
  • US 7,645,459 B2
  • Filed: 04/15/2005
  • Issued: 01/12/2010
  • Est. Priority Date: 05/24/2004
  • Status: Active Grant
First Claim
Patent Images

1. An oral dosage form having pharmaceutically effective absorption comprising:

  • (a) from about 1 mg to about 500 mg of a bisphosphonate which is selected from the group consisting of risedronate and acids, salts, and esters thereof;

    (b) from about 10 mg to about 500 mg of EDTA; and

    (c) a delayed release mechanism to deliver the bisphosphonate and the EDTA in the lower gastrointestinal tract.

View all claims
  • 7 Assignments
Timeline View
Assignment View
    ×
    ×